Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Hubei Jumpcan Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-243.75 Million ≈ $-35.67 Million USD) by net assets (CN¥13.86 Billion ≈ $2.03 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Cash flow conversion efficiency of Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. This chart illustrates how Hubei Jumpcan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Hubei Jumpcan Pharmaceutical Co Ltd for real-time trading data and today's change.
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Hubei Jumpcan Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hubei Jumpcan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hubei Jumpcan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Hubei Jumpcan Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Xinchao Energy Co Ltd
SHG:600777
|
0.063x |
|
Walsin Technology Corp
TW:2492
|
0.013x |
|
Caesars Entertainment Corporation
NASDAQ:CZR
|
0.080x |
|
Indian Railway Catering And Tourism Corporation Limited
NSE:IRCTC
|
0.193x |
|
Trex Company Inc
NYSE:TREX
|
-0.119x |
|
PTC INDUSTRIES LTD
NSE:PTCIL
|
-0.027x |
|
Allete Inc
NYSE:ALE
|
0.031x |
|
Sezzle Inc.
NASDAQ:SEZL
|
0.224x |
Annual Cash Flow Conversion Efficiency for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
The table below shows the annual cash flow conversion efficiency of Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. Review how much free cash does Hubei Jumpcan Pharmaceutical Co Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥14.63 Billion ≈ $2.14 Billion |
CN¥1.20 Billion ≈ $175.35 Million |
0.082x | -44.59% |
| 2024-12-31 | CN¥14.73 Billion ≈ $2.15 Billion |
CN¥2.18 Billion ≈ $318.48 Million |
0.148x | -42.96% |
| 2023-12-31 | CN¥13.37 Billion ≈ $1.96 Billion |
CN¥3.46 Billion ≈ $506.89 Million |
0.259x | +12.24% |
| 2022-12-31 | CN¥11.35 Billion ≈ $1.66 Billion |
CN¥2.62 Billion ≈ $383.51 Million |
0.231x | +11.28% |
| 2021-12-31 | CN¥9.13 Billion ≈ $1.34 Billion |
CN¥1.89 Billion ≈ $277.20 Million |
0.207x | -9.61% |
| 2020-12-31 | CN¥7.76 Billion ≈ $1.14 Billion |
CN¥1.78 Billion ≈ $260.72 Million |
0.230x | -34.77% |
| 2019-12-31 | CN¥6.10 Billion ≈ $893.27 Million |
CN¥2.15 Billion ≈ $314.27 Million |
0.352x | +12.35% |
| 2018-12-31 | CN¥5.46 Billion ≈ $798.65 Million |
CN¥1.71 Billion ≈ $250.10 Million |
0.313x | +15.96% |
| 2017-12-31 | CN¥4.40 Billion ≈ $644.12 Million |
CN¥1.19 Billion ≈ $173.95 Million |
0.270x | +9.06% |
| 2016-12-31 | CN¥3.69 Billion ≈ $539.60 Million |
CN¥913.10 Million ≈ $133.61 Million |
0.248x | +4.07% |
| 2015-12-31 | CN¥2.71 Billion ≈ $396.97 Million |
CN¥645.48 Million ≈ $94.45 Million |
0.238x | -11.41% |
| 2014-12-31 | CN¥2.29 Billion ≈ $335.68 Million |
CN¥616.11 Million ≈ $90.16 Million |
0.269x | +7.78% |
| 2013-12-31 | CN¥1.15 Billion ≈ $168.63 Million |
CN¥287.16 Million ≈ $42.02 Million |
0.249x | +352.79% |
| 2012-12-31 | CN¥490.80 Million ≈ $71.82 Million |
CN¥27.01 Million ≈ $3.95 Million |
0.055x | +6950.17% |
| 2011-12-31 | CN¥526.82 Million ≈ $77.09 Million |
CN¥411.24K ≈ $60.18K |
0.001x | -99.21% |
| 2010-12-31 | CN¥520.27 Million ≈ $76.13 Million |
CN¥51.13 Million ≈ $7.48 Million |
0.098x | +924.94% |
| 2009-12-31 | CN¥512.85 Million ≈ $75.05 Million |
CN¥4.92 Million ≈ $719.55K |
0.010x | -78.95% |
| 2008-12-31 | CN¥506.18 Million ≈ $74.07 Million |
CN¥23.05 Million ≈ $3.37 Million |
0.046x | -38.13% |
| 2007-12-31 | CN¥498.83 Million ≈ $72.99 Million |
CN¥36.72 Million ≈ $5.37 Million |
0.074x | +743.02% |
| 2006-12-31 | CN¥485.82 Million ≈ $71.09 Million |
CN¥4.24 Million ≈ $620.77K |
0.009x | -93.38% |
| 2005-12-31 | CN¥480.25 Million ≈ $70.28 Million |
CN¥63.38 Million ≈ $9.27 Million |
0.132x | +265.74% |
| 2004-12-31 | CN¥473.92 Million ≈ $69.35 Million |
CN¥-37.74 Million ≈ $-5.52 Million |
-0.080x | -1755.48% |
| 2003-12-31 | CN¥466.47 Million ≈ $68.26 Million |
CN¥2.24 Million ≈ $328.32K |
0.005x | -89.96% |
| 2002-12-31 | CN¥459.05 Million ≈ $67.17 Million |
CN¥22.00 Million ≈ $3.22 Million |
0.048x | +190.19% |
| 2001-12-31 | CN¥449.57 Million ≈ $65.79 Million |
CN¥7.43 Million ≈ $1.09 Million |
0.017x | -90.25% |
| 2000-12-31 | CN¥140.01 Million ≈ $20.49 Million |
CN¥23.73 Million ≈ $3.47 Million |
0.169x | -- |
About Hubei Jumpcan Pharmaceutical Co Ltd
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.